An archived replay will be available on the Investors section of the atai website under Events for up to 90 days. About atai Life Sciences atai is a clinical-stage biopharmaceutical company aiming ...

atai Life Sciences (ATAI) announced that the first patient has been dosed in the Phase 2 Elumina trial of VLS-01, atai’s proprietary oral transmucosal film formulation of N,N-Dimethyltryptamine ...

KNOXVILLE, Tenn. (WATE) — After about a decade of wrestling in Egypt, Ahmed Shahin suited up for West High School this season. “He’s extremely explosive. He’s probably one of the best ...

In this article, we are going to take a look at where Atai Life Sciences N.V. (NASDAQ:ATAI) stands against the other psychedelic stocks. In contrast to drugs like cocaine or marijuana ...

atai is enrolling patients into Elumina, the Phase 2, multi-center, double-blind, randomized, placebo-controlled, trial to assess the efficacy, safety and tolerability of VLS-01 in people ...

In January 2024, atai made a strategic investment in Beckley Psytech, resulting in an approximate one third ownership stake and 1:1 warrant coverage at a 30% premium on the primary issuances. atai ...

In this article, we are going to take a look at where Atai Life Sciences N.V. (NASDAQ:ATAI) stands against other stocks with at least $20 million in insider spending recently. As the stock market ...

Details of the company’s participation: Format: Fireside chat and 1x1 investor meetingsDate and Time: Fireside chat o NEW YORK and BERLIN, Feb. 20, 2025 (GLOBE NEWSWIRE) -- atai Life Sciences ...

ATAI DOSES FIRST PATIENT IN PHASE 2 VLS-01 TRIAL: atai Life Sciences (ATAI) announced Tuesday that the first patient has been dosed in the Phase 2 Elumina trial of VLS-01, atai’s proprietary ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...